Article metrics

other Versions

Download PDFPDF
A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)

 

Online download statistics by month:

Online download statistics by month: June 2020 to April 2024

AbstractFullPdf
Jun 20203661812
Jul 202011223
Aug 20207822
Sep 202011643
Oct 202030473
Nov 2020261158
Dec 2020194136
Jan 20219542
Feb 20219100
Mar 202110022
Apr 202111151
May 20214021
Jun 2021412
Jul 2021733
Aug 2021723
Sep 2021200
Oct 20215900
Nov 20219221
Dec 20215532
Jan 202210543
Feb 202210271
Mar 20227492
Apr 20226521
May 20229572
Jun 20226220
Jul 20227551
Aug 202213812
Sep 202211460
Oct 202210720
Nov 20224100
Dec 202211033
Jan 20234310
Feb 20238411
Mar 20234711
Apr 20234935
May 20232421
Jun 20232110
Jul 20235520
Aug 20234911
Sep 20234872
Oct 20234210
Nov 20235500
Dec 202310461
Jan 20246800
Feb 20247312
Mar 20246332
Apr 20242100
Total402816385